MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.85
-0.06 (-0.30%)
Jun 30, 2026, 11:43 AM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.64 billion as of June 30, 2026. Its market cap has decreased by -41.31% in one year.
Market Cap
1.64B
Enterprise Value
1.39B
1-Year Change
-41.31%
Ranking
Category
Stock Price
$19.85
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.64B, an increase of 45,477.53%. That is a compound annual growth rate of 305.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 1.64B | 74.33% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.69B |
| Mesoblast | 1.69B |
| Septerna | 1.68B |
| UroGen Pharma | 1.68B |
| Fortrea Holdings | 1.67B |
| Zenas BioPharma | 1.63B |
| Aktis Oncology | 1.63B |
| Maravai LifeSciences Holdings | 1.61B |